alpha-Tocopherol protective effects on gentamicin ototoxicity: an experimental study.
Gentamicin, acting as an iron chelator, activates membrane lipid peroxidation (MPL) and induces free radical formation, as observed in vitro and in vivo. Antioxidants, such as alpha-tocopherol, are able to suppress MLP, thus attenuating tissue damage. The present study was designed to investigate the possible protective effects of alpha-tocopherol on gentamicin ototoxicity. The study was carried out on albino guinea pigs (250-350 g). The animals were divided into four groups: group A (n = 4), injected with corn oil daily at a dose of 100 mg/kg body weight intramuscularly (IM); group B (n = 10), treated with corn oil at a dose of 100 mg/kg body weight and gentamicin base at a dose of 100 mg/kg body weight (IM); group C (n = 10). treated with gentamicin alone at a dose of 100 mg/kg body weight (IM); and group D (n = 10), treated with gentamicin at the same dose plus alpha-tocopherol acetate at dose of 100 mg/kg body weight (IM). Electrocochleographic recordings were made from an implanted round-window electrode. All animals were treated for 14 days. The compound action potentials (CAPs) were measured at 2-16 kHz at days 0, 10, 14 and 18 after treatment. Changes in cochlear function were characterized as CAP threshold shifts. Morphological changes were analysed by scanning electron microscopy. Gentamicin induced progressive high-frequency hearing loss of 50-60 dB SPL. alpha-Tocopherol co-therapy slowed the progression of hearing loss. The significant loss of outer hair cells (OHCs) in the cochlear basal turn in gentamicin-treated animals was not observed in the cochleas of animals protected with alpha-tocopherol. This study supports the hypothesis that alpha-tocopherol interferes with gentamicin-induced free radical formation, and suggests that this drug may be useful in protecting OHC function from aminoglycoside ototoxicity, thus reducing hearing loss.
Fetoni
Anna Rita
AR
Institute of Otolaryngology, Catholic University of Rome, Rome, Italy.
Sergi
Bruno
B
Ferraresi
Aldo
A
Paludetti
Gaetano
G
Troiani
Diana
D
D000200:Action Potentials / Q000187:drug effects; D000704:Analysis of Variance; D000818:Animals; D000900:Anti-Bacterial Agents / Q000633:toxicity*; D000975:Antioxidants / Q000627:therapeutic use*; D001300:Audiometry, Evoked Response; D003051:Cochlea / Q000033:anatomy & histology / Q000187:drug effects / Q000502:physiology; D004594:Electrophysiology; D005839:Gentamicins / Q000633:toxicity*; D006168:Guinea Pigs; D018072:Hair Cells, Auditory, Outer / Q000187:drug effects* / Q000502:physiology / Q000648:ultrastructure; D034381:Hearing Loss / Q000139:chemically induced / Q000517:prevention & control*; D008855:Microscopy, Electron, Scanning; D016896:Treatment Outcome; D024502:alpha-Tocopherol / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D000975:Antioxidants; D005839:Gentamicins; D024502:alpha-Tocopherol